Enteric coated pharmaceutical dosage form, process for preparing it, using it, pellet or tablet fitted to it, and, processes to improve the inhibition of gastric acid secretion, and to improve the therapeutic effect in the treatment of associated gastrointestinal disorders with excess acid secretion

摘要

"ENTERED-COATED PHARMACEUTICAL DOSAGE FORM, PROCESS FOR THE PREPARATION OF THE SAME, USE OF THIS, PELLET OR TABLET ORDERED FOR THE SAME, AND, PROCESSES TO IMPROVE THE INHIBITION OF THE GERTRIC ACID SECRETATION, AND TO IMPROVE THE TREATMENT OF TREATMENT IN THE TREATMENT OF TREATMENT OF TREATMENT. ASSOCIATED WITH EXCESSIVE ACID SECRETATION ". Enteric coated pharmaceutical dosage form, comprising H ^ + ^, K ^ + ^ -ATPase inhibitor. The dosage form comprises at least two parts of the H ^ + ^, K ^ + ^ -ATPase inhibitor to be released in at least two consecutive pulses. The dosage form has at least one fraction with a delayed pulsed release and another fraction with instantaneous release of the H ^ + ^, K ^ + ^ -ATPase inhibitor. The parts are released in time in the range of 0.5 and up to 12 hours, preferably from 0.5 and up to 8 hours and more preferably from 0.5 and up to 4 hours apart. The dosage form is intended for administration once a day.